Sapient Therapeutics

Hemp plants being used in scientific research
#Cannabinoid #Medicinal cannabis #Neuroscience #Phase I trial #Sapient Therapeutics

Positive Phase I results for solid dose prescription CBD medicine

Positive Phase I results for a new solid dose prescription cannabidiol (CBD) demonstrate the tolerability and bioavailability of the drug. Neuroscience drug discovery company Sapient Therapeutics successfully completed Part B of the Phase I trial comparing its CBD therapy SAP021 with Epidiolex. The trial… Read More

#News